SAN FRANCISCO—Slightly more than half of patients with refractory idiopathic detrusor overactivity (IDO) incontinence have complete restoration of continence one month after intradetrusor injections ...

May 13, 2004 (San Francisco) -- Injections of botulinum toxin A (Botox) can be helpful in addressing several types of bladder dysfunction problems, according to findings presented here at the 99th ...

(HealthDay News) — Intradetrusor injection of onabotulinumtoxin A is safe and effective for bladder chemodenervation in overactive bladder, with new approaches being developed to increase toxin ...

Injection of botulinum toxin type A into the detrusor smooth muscle is a minimally invasive treatment for incontinence related to neurogenic detrusor overactivity; re-injection is usually necessary ...

A single series of intrarectal botulinum toxin type A injections may provide significant improvement in fecal incontinence symptoms. Submucosal intrarectal injections of botulinum toxin type A (BoNTA) ...

Pharmacologic therapy may improve symptoms in patients with refractory overactive bladder who receive intravesical onabotulinum toxin-A injections. Adding a beta-3 agonist to treatment may increase ...

NORTH CHICAGO, Ill., Feb. 10, 2021 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) has approved BOTOX® for the treatment of ...

FDA issued 18 warning letters to websites selling unapproved or misbranded botulinum toxin products. Officials say the unregulated injections have been tied to botulism-like symptoms in consumers.